Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details) - USD ($) $ in Thousands |
3 Months Ended | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|||||||||||||||
| Revenues [Abstract] | ||||||||||||||||
| Revenues | $ 252,537 | $ 245,001 | ||||||||||||||
| Depreciation and amortization | (9,922) | (9,051) | ||||||||||||||
| Income tax provision | (1,364) | (3,379) | ||||||||||||||
| Interest expense | (16,331) | (29,849) | ||||||||||||||
| Loss on disposal of property and equipment | (137) | 162 | ||||||||||||||
| Stock-based compensation | (12,274) | (6,374) | ||||||||||||||
| NET INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS) | 1,717 | (7,687) | ||||||||||||||
| Patient Service Revenue | ||||||||||||||||
| Revenues [Abstract] | ||||||||||||||||
| Revenues | 188,992 | 184,217 | ||||||||||||||
| Operating Segments | ||||||||||||||||
| Revenues [Abstract] | ||||||||||||||||
| Revenues | 252,537 | 245,001 | ||||||||||||||
| Other segment items | [1] | 201,338 | 194,002 | |||||||||||||
| Adjusted EBITDA | 51,199 | 50,999 | ||||||||||||||
| Depreciation and amortization | (9,922) | (9,051) | ||||||||||||||
| Income tax provision | (1,364) | (3,379) | ||||||||||||||
| Amortization of basis difference | (531) | (500) | ||||||||||||||
| Interest expense | (16,331) | (29,849) | ||||||||||||||
| Loss on disposal of property and equipment | (137) | 162 | ||||||||||||||
| Stock-based compensation | (12,274) | (6,374) | ||||||||||||||
| Severance and executive recruiting | [2] | (945) | (1,370) | |||||||||||||
| Strategic initiatives and implementation | [3] | (825) | (868) | |||||||||||||
| Transaction costs | [4] | (2,582) | (3,588) | |||||||||||||
| Litigation and settlements | [5] | (29) | 128 | |||||||||||||
| Other | [6] | 5 | (22) | |||||||||||||
| Adjustments for equity in earnings of unconsolidated affiliates | [7] | (4,547) | (3,975) | |||||||||||||
| NET INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS) | 1,717 | (7,687) | ||||||||||||||
| Operating Segments | Patient Service Revenue | ||||||||||||||||
| Revenues [Abstract] | ||||||||||||||||
| Revenues | 197,318 | 192,298 | ||||||||||||||
| Operating Segments | Management Fee and Other Revenue [Member] | ||||||||||||||||
| Revenues [Abstract] | ||||||||||||||||
| Revenues | 55,219 | 52,703 | ||||||||||||||
| Operating Segments | Outpatient | ||||||||||||||||
| Revenues [Abstract] | ||||||||||||||||
| Revenues | 187,899 | 180,801 | ||||||||||||||
| Other segment items | [1] | 149,526 | 138,979 | |||||||||||||
| Adjusted EBITDA | 38,373 | 41,822 | ||||||||||||||
| Operating Segments | Outpatient | Patient Service Revenue | ||||||||||||||||
| Revenues [Abstract] | ||||||||||||||||
| Revenues | 138,092 | 133,430 | ||||||||||||||
| Operating Segments | Outpatient | Management Fee and Other Revenue [Member] | ||||||||||||||||
| Revenues [Abstract] | ||||||||||||||||
| Revenues | 49,807 | 47,371 | ||||||||||||||
| Operating Segments | Professional | ||||||||||||||||
| Revenues [Abstract] | ||||||||||||||||
| Revenues | 68,158 | 65,886 | ||||||||||||||
| Other segment items | [1] | 55,332 | 56,709 | |||||||||||||
| Adjusted EBITDA | 12,826 | 9,177 | ||||||||||||||
| Operating Segments | Professional | Patient Service Revenue | ||||||||||||||||
| Revenues [Abstract] | ||||||||||||||||
| Revenues | 62,746 | 60,554 | ||||||||||||||
| Operating Segments | Professional | Management Fee and Other Revenue [Member] | ||||||||||||||||
| Revenues [Abstract] | ||||||||||||||||
| Revenues | 5,412 | 5,332 | ||||||||||||||
| Operating Segments | Intersegment Eliminations | ||||||||||||||||
| Revenues [Abstract] | ||||||||||||||||
| Revenues | (3,520) | (1,686) | ||||||||||||||
| Other segment items | [1] | (3,520) | (1,686) | |||||||||||||
| Adjusted EBITDA | 0 | 0 | ||||||||||||||
| Operating Segments | Intersegment Eliminations | Patient Service Revenue | ||||||||||||||||
| Revenues [Abstract] | ||||||||||||||||
| Revenues | (3,520) | (1,686) | ||||||||||||||
| Operating Segments | Intersegment Eliminations | Management Fee and Other Revenue [Member] | ||||||||||||||||
| Revenues [Abstract] | ||||||||||||||||
| Revenues | $ 0 | $ 0 | ||||||||||||||
| ||||||||||||||||
| X | ||||||||||
- Definition Adjusted EBITDA from continuing operations. No definition available.
|
| X | ||||||||||
- Definition Adjustments for equity in earnings of unconsolidated affiliates. No definition available.
|
| X | ||||||||||
- Definition Severance and executive recruiting. No definition available.
|
| X | ||||||||||
- Definition Strategic initiatives and implementation. No definition available.
|
| X | ||||||||||
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for acquisition-related cost incurred to effect business combination. Includes, but is not limited to, finder's fee; advisory, legal, accounting, valuation, and other professional and consulting fees; and general administrative cost, including cost of maintaining internal acquisition department. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue and income classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|